H.C. Wainwright raised the firm’s price target on MacroGenics to $16 from $14 and keeps a Neutral rating on the shares following the Q4 report.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MGNX:
